From insight to impact: Leveraging the AI-enabled Next platform with BMS to advance equitable access in precision oncology

May 27, 2026
Life Sciences
Webinar
Black and white headshot of a bald man smiling, wearing a suit jacket.Andrew WhiteheadVP, Head of Population Health
Smiling man with short dark hair and a beard, wearing a collared shirt.Noah Zimmerman, PhD VP & GM, Next Oncology, Tempus
Black and white headshot of a smiling man wearing glasses and a striped jacket.Dr. Gary Grad Senior Medical Oncologist, Tempus

Session highlights

  • How AI-enabled platforms unify structured and unstructured data to reveal the "why" behind care decisions.

  • Real-world results, including an 8% lift in guideline-directed testing.

  • A discussion of how Tempus Next Pathways insights can support improved outcomes for patients, providers, and life sciences partners.

Related content

White square with a folded top-left corner on a dark background.Webinar
Abstract background with subtle wavy lines creating a dynamic pattern in shades of grey.

Expanding horizons: Tempus AI’s sequencing and data capabilities in Japan

2026-08-25
Life Sciences
White square with a folded top-left corner on a dark background.Webinar
Abstract background with subtle wavy lines transitioning from grey to blue.

Revealing the full patient story: From multimodal longitudinal data to predictive insights

2026-08-20
Life Sciences
White square with a folded top-left corner on a dark background.Webinar
Abstract gray pattern with two distinct vertical black lines and radiating oval shapes.

Powering scientific breakthroughs: How to drive research with Tempus Lens

2026-07-23
Life Sciences